Last reviewed · How we verify
Double matched sibling transplantation — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Double matched sibling transplantation (Double matched sibling transplantation) — Rabin Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Double matched sibling transplantation TARGET | Double matched sibling transplantation | Rabin Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Double matched sibling transplantation CI watch — RSS
- Double matched sibling transplantation CI watch — Atom
- Double matched sibling transplantation CI watch — JSON
- Double matched sibling transplantation alone — RSS
Cite this brief
Drug Landscape (2026). Double matched sibling transplantation — Competitive Intelligence Brief. https://druglandscape.com/ci/double-matched-sibling-transplantation. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing